Roselabs Finance re-appoints Raghava Reddy Balineni as MD for 5 years

1 min read     Updated on 29 May 2026, 06:43 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Roselabs Finance has approved the re-appointment of Mr. Raghava Reddy Balineni as Managing Director for a term of five years effective May 31, 2026, pending shareholder approval. Mr. Balineni brings over three decades of experience in taxation and general management, having previously led indirect taxation at Lodha Group, ArcelorMittal Nippon Steel India Limited, and Essar Group.

powered bylight_fuzz_icon
41605991

*this image is generated using AI for illustrative purposes only.

Roselabs Finance has approved the re-appointment of Mr. Raghava Reddy Balineni as Managing Director for a term of five years, effective May 31, 2026. The decision, taken by the Board of Directors at its meeting on May 29, 2026, is subject to the approval of the company's shareholders. This leadership continuity is aimed at maintaining the strategic direction of the non-banking financial company.

The re-appointment follows the recommendations of the Nomination and Remuneration Committee. Mr. Balineni, who holds a DIN of 09185972, is not related inter-se to any other director on the board. He is also not debarred from holding the office of director by virtue of any SEBI order or any other authority, as per disclosures required under relevant BSE and NSE circulars dated June 20, 2018.

Profile of the Managing Director

Mr. Raghava Reddy Balineni is a Commerce graduate from Andhra University and holds a degree in Law from Osmania University. He possesses more than 31 years of experience in taxation and general management. His professional background includes leadership roles in prominent organizations.

Prior to his current role, he has been associated with the Lodha Group since 2020 as the Head of Indirect Taxation. Before joining the Lodha Group, he served as the Head of Indirect Tax at ArcelorMittal Nippon Steel India Limited and the Essar Group.

Key Appointment Details

The table below outlines the specific details regarding the re-appointment:

Sr. No. Particulars Description
1 Reason for change Re-appointment
2 Date of appointment & term Re-appointed as Managing Director for a term of 5 years with effect from May 31, 2026, subject to approval of the shareholders.
3 Regulatory disclosure Mr. Raghava Reddy Balineni is not debarred from holding the office of director by virtue of any SEBI order or any other such authority.

Historical Stock Returns for Roselabs Finance

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+10.05%-4.58%-8.48%-35.91%-28.91%

What strategic growth initiatives does Mr. Balineni plan to prioritize during his new five-year term?

How will the leadership continuity influence Roselabs Finance's competitive position in the NBFC sector?

What are the expected market reactions from shareholders regarding the re-appointment proposal?

Roselabs Finance Publishes Audited Financial Results in Newspapers for FY26

2 min read     Updated on 17 Apr 2026, 11:53 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Roselabs Finance Limited completed newspaper publication of its FY26 audited financial results in Financial Express and Mumbai Lakshadeep as per SEBI regulations. The company reported revenue growth to ₹120.75 lakhs but sustained losses of ₹30.70 lakhs, with results approved by the Board on April 16, 2026.

powered bylight_fuzz_icon
37601716

*this image is generated using AI for illustrative purposes only.

Roselabs Finance Limited has completed the newspaper publication of its audited financial results for the quarter and financial year ended March 31, 2026, following regulatory compliance requirements. The company published its results in Financial Express and Mumbai Lakshadeep newspapers on April 17, 2026.

Regulatory Compliance and Publication

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company informed BSE Limited about the newspaper publication of its audited financial results. Company Secretary and Compliance Officer Gunjan Taunk signed the official communication confirming the publication in both newspapers.

Publication Details: Information
Publication Date: April 17, 2026
Newspapers: Financial Express, Mumbai Lakshadeep
Scrip Code: 531324
Website Upload: www.roselabsfinancelimited.in

Financial Performance Overview

The company's audited financial results for FY26 showed revenue from operations of ₹120.75 lakhs, representing a significant increase from ₹70.91 lakhs in FY25. However, the company reported a net loss of ₹30.70 lakhs for FY26, compared to a net loss of ₹29.17 lakhs in the previous financial year.

Financial Metric: FY26 (₹ Lakhs) FY25 (₹ Lakhs) Change
Revenue from Operations: 120.75 70.91 +70.30%
Total Income: 120.75 72.59 +66.35%
Total Expenses: 140.53 101.76 +38.09%
Net Loss: (30.70) (29.17) -5.25%
Earnings Per Share: (0.31) (0.29) -6.90%

Board Approval and Audit Details

The Board of Directors approved the audited financial results at their meeting held on April 16, 2026, which commenced at 5:30 PM IST and concluded at 5:55 PM IST. M/s. MSKA & Associates LLP, Chartered Accountants, served as the statutory auditors and issued an unmodified audit opinion on the financial results.

Balance Sheet Position

The company's financial position as of March 31, 2026, shows total assets of ₹5.88 lakhs, down from ₹22.65 lakhs in the previous year. The equity position remains negative at ₹503.46 lakhs, with borrowings of ₹507.45 lakhs supporting operations.

Balance Sheet Item: March 31, 2026 (₹ Lakhs) March 31, 2025 (₹ Lakhs)
Total Assets: 5.88 22.65
Equity Share Capital: 1,000.00 1,000.00
Other Equity: (1,503.46) (1,472.76)
Borrowings: 507.45 493.35

The complete audited financial results along with the auditor's report are available on BSE's website at www.bseindia.com and the company's website at www.roselabsfinancelimited.in , accessible through the provided QR code in the newspaper publication.

Historical Stock Returns for Roselabs Finance

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%+10.05%-4.58%-8.48%-35.91%-28.91%

What strategic initiatives will Roselabs Finance implement to convert its 70% revenue growth into profitability in FY27?

How does the company plan to address its deteriorating balance sheet position with total assets declining from ₹22.65 lakhs to ₹5.88 lakhs?

Will Roselabs Finance need to raise additional capital or restructure its ₹507.45 lakhs borrowings to improve its negative equity position?

More News on Roselabs Finance

1 Year Returns:-35.91%